Pulmonologists share best practices on when primary care providers should consider sending patients with respiratory ...

A surge of generics, biosimilars, and innovative therapies is expected in 2025, addressing conditions from cancer to chronic ...

Frexalimab was well tolerated and maintained disease control over two years in adults with relapsing MS in an open-label ...

EXCLUSIVE: The sister of a man whose deadly bladder cancer only reared its head when it was tragically too late has revealed ...

technegas allows doctor-operators to visualise a patients’ lungs without the need for PET scans and other such pathways. Being scanned for: Pulmonary embolism (PE) and venous thromboembolism (VTE).

Bayer will present new data for NUBEQA® (darolutamide) in prostate cancer at the upcoming American Urological Association (AUA) Annual Meeting taking place in Las Vegas from April 26-29, 2025. These ...

AbbVie (NYSE: ABBV) today announced that the European Commission (EC) granted marketing authorization to RINVOQ� (upadacitinib; 15 mg, once daily) for the treatment of giant cell arteritis (GCA) in ...

Clinical decision pathways should be used routinely in emergency departments ... pericarditis, myocarditis, pulmonary embolism, pneumothorax, pneumonia, and peptic ulcer. ACS is frequently caused by ...

The Trump administration has pressed forwards with plans to unleash a wave of trillions in public spending cuts ...